News about "Precision Medicine"

Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio

Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.

Precision Medicine | 30/05/2026 | By News Bureau

Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors

Genethon and Ampersand Biomedicines join forces to engineer advanced AAV gene therapy vectors designed for greater tissue specificity, potentially enabling safer and more effective treatments for patients with rare genetic disorders.

Precision Medicine | 25/05/2026 | By News Bureau

Dr. Jitendra Singh Launches UMMID Program, Highlights Future of Genomic and Precision Medicine

Dr. Jitendra Singh dedicates the UMMID Program to the nation, highlighting the growing role of genomic and precision medicine in advancing early intervention, personalised treatment, and affordable healthcare for rare genetic disorders in India.

Precision Medicine | 22/05/2026 | By News Bureau

Thryv Therapeutics Advances THRV-1268 Programme with Phase II/III Trial and FDA Fast Track Status

Thryv Therapeutics initiates Phase II/III clinical testing and secures FDA Fast Track status for THRV-1268, advancing a potential first-in-class therapy for Long QT Syndrome.

Precision Medicine | 27/04/2026 | By News Bureau

GlycoNex Secures PMDA Nod for First-in-Human Trial of Cancer Drug GNX1021

Japan’s Pharmaceuticals and Medical Devices Agency approves Phase I clinical trial of GlycoNex’s novel antibody-drug conjugate targeting gastrointestinal cancers.

Precision Medicine | 16/04/2026 | By News Bureau |  127

PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026

PrecisionLife and Ovation partner to launch GLP-1 stratification LDT and consumer DNA test in 2026, with early data showing distinct genetic markers for weight loss and glycemic control.

Precision Medicine | 16/04/2026 | By News Bureau

Alltrna Receives Approval to Begin First-in-Human Trial of tRNA Therapeutic AP003

Alltrna initiates first-in-human trial of engineered tRNA therapy AP003 in Australia, marking a breakthrough in genetic disease treatment.

Precision Medicine | 01/04/2026 | By News Bureau |  217

Caris Study Shows AI Tool Improves Accuracy in Lung Cancer Diagnosis

Caris Life Sciences finds its GPSai algorithm can identify misdiagnosed lung cancer cases, potentially improving treatment decisions and outcomes through AI-driven molecular profiling.

Precision Medicine | 24/03/2026 | By News Bureau

Bayer and VUMC Partner to Advance Cardiovascular and Kidney Therapies

The collaboration will focus initially on cardiovascular and kidney diseases, combining Bayer’s drug development expertise with Vanderbilt University Medical Center’s extensive data resources to generate data-driven insights and accelerate the discovery and development of new therapies addressing significant unmet medical needs.

Precision Medicine | 21/01/2026 | By News Bureau |  150

Jacobio Pharma Signs Global Licensing Deal with AstraZeneca for Pan-KRAS Drug

Under the agreement, Jacobio will receive USD 100 million upfront and is eligible for up to USD 1.915 billion in development and commercial milestones, along with tiered royalties on ex-China sales, while AstraZeneca will lead all ex-China development, regulatory and commercial activities for JAB-23E73.

Precision Medicine | 22/12/2025 | By News Bureau |  190